Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series of<i>in vitro</i>breast cancer models
Carol Ward(MRC Institute of Genetics and Molecular Medicine), Simon P. Langdon(MRC Institute of Genetics and Molecular Medicine)
Cited by 96
Related Papers
Expression of glycolytic enzymes in ovarian cancers and evaluation of the glycolytic pathway as a strategy for ovarian cancer treatment
|BMC Cancer|2018|107
HER2 regulates HIF-2α and drives an increased hypoxic response in breast cancer
|Breast Cancer Research|2019|69
Sensitivity to pertuzumab (2C4) in ovarian cancer models: cross-talk with estrogen receptor signaling
|Molecular Cancer Therapeutics|2007|55
Defining the molecular response to trastuzumab, pertuzumab and combination therapy in ovarian cancer
|British Journal of Cancer|2012|49